India has confirmed 1,600 million dose purchases as of December 18, which equates to roughly one injection per person
No less than 10 countries have started administering COVID-19 vaccines even as the number of trial candidates more than doubled in December compared to August. Three vaccines, developed by Pfizer-BioNTech, Moderna Inc. and Sinopharm, have been fully approved by various countries. India, pending the deployment of its vaccine, has reserved around 1.6 billion doses, or about one dose per person. Most of the leading vaccine candidates require two doses per person.
The graph shows the number of candidate vaccines across the different phases of testing as of August 17, November 25, and December 27. Sixty-four vaccines are in clinical trials in humans, up from 30 in August.
Vaccine doses administered
The map shows the number of vaccine doses administered in countries. The darker the shade, the greater the number of doses. The United States led the way with around 1.9 million doses administered as of December 26.
Also read: Data | Confidence in COVID-19 vaccines remains high among Indians
Doses per lakh
The graph shows the number of doses of vaccine administered per 1 lakh of inhabitants in a country. It is important to note that the numbers do not represent the number of people, but the number of doses given.
As vaccinations in many countries began, the spotlight turned to the anticipated market commitments obtained by countries for such vaccines. India has confirmed 1,600 million dose purchases as of December 18, which equates to about one injection per person.
Note: All data as of December 26
Source: Our World in Data, NYT, Duke Global Health Innovation Center
Also read: Data | Three government investigations refute Swachh Bharat’s 100% ODF claim